RYI-018: A Monoclonal Antibody Cannabinoid Receptor 1 Inverse Agonist For The Treatment of Metabolic Diseases

被引：0
|
作者：
Kretz-Rommel, Anke [1 ]
Ferrini, Roger [1 ]
Mann, Derek [2 ]
Shi, Lei [3 ]
Yang, Teddy [3 ]
Glicklich, Alan [1 ]
Grayson, Paul [1 ]
机构：
[1] Bird Rock Bio Inc, La Jolla, CA USA
[2] Newcaste Univ, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England
[3] RuiYi, Shanghai, Peoples R China
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1153
引用
下载
收藏
页码：581A / 581A
页数：1
相关论文
共 50 条
  • [41] F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist
    Shen, CP
    Xiao, JC
    Armstrong, H
    Hagmann, W
    Fong, TM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 531 (1-3) : 41 - 46
  • [42] Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice
    Pryce, Gareth
    Baker, David
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (21) : 3790 - 3794
  • [43] ACTIVATION OF THE TRKB RECEPTOR PATHWAY USING A NOVEL MONOCLONAL ANTIBODY AGONIST: IMPLICATIONS FOR THE TREATMENT OF HUNTINGTON'S DISEASE
    Carty, N.
    Schmidt, L.
    Bursow, G.
    Schwagarus, T.
    Graff, C.
    Damrath, E.
    Kuhlbrodt, K.
    Kohler, M.
    Koeplin, S.
    Salomon, K.
    Jaeger, S.
    Gemkow, M.
    von der Kammer, H.
    Wityak, J.
    Munoz-Sanjuan, I.
    Bard, J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A101 - A101
  • [44] Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
    Charles W Schindler
    Godfrey H Redhi
    Kiran Vemuri
    Alexandros Makriyannis
    Bernard Le Foll
    Jack Bergman
    Steven R Goldberg
    Zuzana Justinova
    Neuropsychopharmacology, 2016, 41 : 2283 - 2293
  • [45] Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys
    Schindler, Charles W.
    Redhi, Godfrey H.
    Vemuri, Kiran
    Makriyannis, Alexandros
    Le Foll, Bernard
    Bergman, Jack
    Goldberg, Steven R.
    Justinova, Zuzana
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 (09) : 2283 - 2293
  • [46] Prolonged maintenance of weight loss and decreased adiposity with chronic cannabinoid CB1 receptor inverse agonist treatment in diet-induced obese mice
    Rosko, K
    Stribling, DS
    Camacho, R
    Zhou, D
    Kuca, S
    Strack, A
    Shearman, L
    OBESITY RESEARCH, 2003, 11 : A118 - A118
  • [47] Identification of key amino acid residues in a thyrotropin receptor monoclonal antibody epitope provides insight into its inverse agonist and antagonist properties
    Chen, Chun-Rong
    McLachlan, Sandra M.
    Rapoport, Basil
    ENDOCRINOLOGY, 2008, 149 (07) : 3427 - 3434
  • [48] The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin mRNA by modulating food intake
    Thornton-Jones, ZD
    Vickers, SP
    Kennett, GA
    Benwell, KR
    Revell, DF
    Misra, A
    Sellwood, DM
    Clifton, PG
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 : S22 - S23
  • [49] Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
    Shearman, LP
    Rosko, KM
    Fleischer, R
    Wang, J
    Xu, S
    Tong, XS
    Rocha, BA
    BEHAVIOURAL PHARMACOLOGY, 2003, 14 (08): : 573 - 582
  • [50] Efficacy in diet-induced obese mice of the hepatotropic, peripheral cannabinoid 1 receptor inverse agonist TM38837
    Cooper, Martin E.
    Norregaard, Pia K.
    Hogberg, Thomas
    Andersson, Gunnar
    Receveur, Jean-Marie
    Linget, Jean-Michel
    Elling, Christian E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
12345